Viewing Study NCT00151060


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-02-01 @ 10:30 PM
Study NCT ID: NCT00151060
Status: COMPLETED
Last Update Posted: 2015-01-21
First Post: 2005-09-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords: